Frontlight ResearchEarly access
Enrolling by invitationNo phase
Prevalence and Clinical Manifestations of Cannabis Withdrawal in Hospitalized Patients With Hematological Malignancies Undergoing Bone Marrow Transplant (BMT) or Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Key facts
- Who runs it
- Mayo Clinic
- Where
- Scottsdale, United StatesSee the site
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 300 people, planned
- Started
- 18 Feb 2026
- Expected to end
- 28 Feb 2031
- Type of study
- Observational
- Treatments tested
- Non-Interventional Study
- Record updated
- 18 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All adult patients admitted for BMT or CAR-T therapy
Who cannot take part
- Individuals unable to provide informed consent
Where in United States
- Mayo Clinic in ArizonaScottsdale, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This study evaluates the prevalence of cannabis withdrawal and the clinical manifestations of cannabis withdrawal syndrome in patients hospitalized for BMT or CAR-T therapy.
The group in the trial
- Observational
Patients complete surveys and have their medical records reviewed on study.
Treatment: Non-Interventional Study
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 18 May 2026